Literature DB >> 15712160

[Functional disorders of FOF1-ATPase in submitochondrial particles obtained from platelets of patients with a diagnosis of probable Alzheimer's disease].

E Martínez-Cano1, G Ortiz-Genaro, F Pacheco-Moisés, M A Macías-Islas, S Sánchez-Nieto, S A Rosales-Corral.   

Abstract

INTRODUCTION: Recent studies indicate that decreased energy generation by mitochondria is a feature that is common across neurodegenerative diseases. PATIENTS AND METHODS: In order to obtain direct evidence that mitochondrial functioning is altered, we measured the hydrolytic activity of F0F1-ATPase and its capacity to generate a stable proton gradient in submitochondrial particles in 29 patients diagnosed with probable Alzheimer's disease (AD). Submitochondrial particles were obtained from platelets of patients with a diagnosis of probable AD and from clinically healthy controls.
RESULTS: Data revealed that the hydrolytic activity of F0F1-ATPase increases significantly in patients with probable AD (41.7+/-4.3 nmol PO4 min-1[mg protein]-1, n=29) as compared to the control subjects (29.1+/-1.9 nmol PO4 min-1 [mg protein]-1, n=29). It is important to note that, in the male population with probable AD, we found that hydrolytic activity of F0F1-ATPase increased as cerebral deterioration progressed. We also detected a lower pH gradient in the submitochondrial particles of patients with probable AD (0.28+/-0.08 pH units, n=25) as compared to the controls (0.5+/-0.1 pH units, n=20).
CONCLUSIONS: Overall, these data point to an alteration in the functioning of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15712160

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  5 in total

1.  Mitochondrial ATPase activity and membrane fluidity changes in rat liver in response to intoxication with buckthorn (Karwinskia humboldtiana).

Authors:  Margarita Cid-Hernández; Ana C Ramírez-Anguiano; Genaro G Ortiz; Eddic W Morales-Sánchez; Luis J González-Ortiz; Sandra F Velasco-Ramírez; Fermín P Pacheco-Moisés
Journal:  Biol Res       Date:  2015-03-19       Impact factor: 5.612

2.  Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease.

Authors:  Simon J Beck; Lan Guo; Aarron Phensy; Jing Tian; Lu Wang; Neha Tandon; Esha Gauba; Lin Lu; Juan M Pascual; Sven Kroener; Heng Du
Journal:  Nat Commun       Date:  2016-05-06       Impact factor: 14.919

3.  New Mechanistic Insights on Carbon Nanotubes' Nanotoxicity Using Isolated Submitochondrial Particles, Molecular Docking, and Nano-QSTR Approaches.

Authors:  Michael González-Durruthy; Riccardo Concu; Juan M Ruso; M Natália D S Cordeiro
Journal:  Biology (Basel)       Date:  2021-02-25

4.  Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy.

Authors:  Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; David Villa-Hernández; Pedro Pablo Hernández-Godínez; Genaro Gabriel Ortiz; Fermín Paul Pacheco-Moisés; Ernesto Germán Cardona-Muñoz; Alejandra Guillermina Miranda-Díaz
Journal:  J Diabetes       Date:  2013-08-21       Impact factor: 4.006

5.  The antioxidant effect of ubiquinone and combined therapy on mitochondrial function in blood cells in non-proliferative diabetic retinopathy: A randomized, double-blind, phase IIa, placebo-controlled study.

Authors:  Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; Luis Miguel Román-Pintos; Fermín Paul Pacheco-Moisés; Alejandra Guillermina Miranda-Díaz
Journal:  Redox Rep       Date:  2016-02-05       Impact factor: 4.412

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.